Gwangmyeong, South Korea

Young-Jin An

This inventor holds 1 USPTO granted patent. Top assignees: Biopoa, Inc., Kbnp, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Jin An. Retrieved from https://idiyas.com/inventor/young-jin-an-x50787yj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Jin An: Innovator in Vaccine Development

Introduction

Young-Jin An is a notable inventor based in Gwangmyeong, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work focuses on creating innovative solutions to combat infectious diseases.

Latest Patents

Young-Jin An holds a patent for an "Attenuated recombinant Newcastle disease virus and vaccine containing the same." This invention relates to a recombinant vector for the transcription of the Newcastle disease virus (NDV) genome. It includes a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV. The patent outlines a method for preparing a recombinant NDV that has low pathogenicity and high protective efficiency against Newcastle disease (ND). Additionally, it describes a vaccine against ND that contains the recombinant NDV. He has 1 patent to his name.

Career Highlights

Throughout his career, Young-Jin An has worked with various companies, including Kbnp, Inc. and Biopoa, Inc. His experience in these organizations has contributed to his expertise in vaccine development and virology.

Collaborations

Young-Jin An has collaborated with notable colleagues such as Sun-Hee Cho and Mi-Joung Ko. These partnerships have enhanced his research and development efforts in the field of infectious diseases.

Conclusion

Young-Jin An is a prominent figure in the realm of vaccine innovation, with a focus on Newcastle disease. His contributions through patents and collaborations highlight his commitment to advancing public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…